Jun 07, 2023 / 04:30PM GMT
Akash Tewari - Jefferies - Analyst
Good morning, everyone. I hope you're enjoying day one of our Jefferies Healthcare Conference. For those who don't know me, my name is Akash Tewari, I'm one of the biotech analysts here. I have the pleasure of hosting the Enanta management team. Why don't I hand it off to Jay and Tara to give some brief introductions and then we'll get into some Q&A.
Jay Luly - Enanta Pharmaceuticals, Inc. - President, CEO, & Director
Sure. Before we begin, I want to remind you that I'll be making some forward-looking statements today. For a summary of the risks associated with these statements, please see our filings on sec.gov and on our website. So I'm Jay Luly, I'm President and CEO of Enanta. I'm sorry, Akash, you just wanted to do name introduction.
Akash Tewari - Jefferies - Analyst
I mean, if you want to give any introductory remarks sure, but otherwise we can get into Q&A.
Jay Luly - Enanta Pharmaceuticals, Inc. - President, CEO, & Director
Enanta Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers